Rheumatoid Arthritis Completed Phase 4 Trials for Adalimumab (DB00051)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

DBCOND0027961 (Rheumatoid Arthritis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00808509A Pilot Study of the Feasibility of Discontinuation of Adalimumab in Stable Rheumatoid Arthritis Patients in Clinical Remission
NCT00837434Anti-TNF Agents for the Treatment of Rheumatoid ArthritisTreatment
NCT02198651A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) SubjectsTreatment
NCT01500278Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to MethotrexateTreatment
NCT01609205Doppler Evaluation in RA Patients After Adalimumab.Treatment
NCT00480272Prospective Study on Intensive Early Rheumatoid Arthritis TreatmentTreatment
NCT00420927Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid ArthritisTreatment
NCT00234884Post-marketing Observational Study in Subjects With Rheumatoid Arthritis
NCT00234897Efficacy of HUMIRA in Subjects With Active Rheumatoid ArthritisTreatment
NCT00234234Predictors of the Response to Adalimumab in Rheumatoid ArthritisTreatment
NCT01270087The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthritis. A Pilot Study.Treatment
NCT00649922Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneumococcal Vaccines in Subjects With Rheumatoid ArthritisTreatment
NCT01382160Serum Concentration of Adalimumab as a Predictive Factor of Clinical Outcomes in Rheumatoid Arthritis (AFORA)
NCT01295151SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug.Treatment
NCT01185288A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA)Treatment
NCT01162421A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid ArthritisTreatment
NCT01119859A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid ArthritisTreatment
NCT01021735Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic TherapyTreatment
NCT00696059Humira in Rheumatoid Arthritis - Do Bone Erosions Heal?Treatment